WideTrial

South San Francisco, United States

WideTrial is a third-party sponsor of group-level Expanded Access programs (EAPs).

$22.0M raised

Nov 2024

Grant

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has WideTrial raised?

WideTrial has raised $22.0M in total funding. The most recent round was Grant. The last funding was announced in November 2024.

Who are WideTrial's investors?

WideTrial's investors include National Institute of Neurological Disorders and Stroke.

Where is WideTrial headquartered?

WideTrial is headquartered in South San Francisco, United States.

What does WideTrial do?

WideTrial is a third-party sponsor of group-level Expanded Access programs (EAPs).

What stage is WideTrial at?

WideTrial is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 19, 2024.

MLA

"WideTrial — Funding & Investors." VCBacked, November 19, 2024, https://www.vcbacked.co/company/widetrial. Accessed July 2, 2026.

APA

VCBacked. (2024). WideTrial — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/widetrial

Wikipedia (cite web)

{{cite web |title=WideTrial — Funding & Investors |url=https://www.vcbacked.co/company/widetrial |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 19, 2024.